APA (7th ed.) Citation

Zhang, Y., Barkdull, S., Kontoyiannis, P. D., Legarreta, A. F., Gershenson, D. M., Ramalingam, P., . . . Sood, A. K. TP53 and KRAS co-mutations are associated with worse outcomes in mucinous ovarian carcinomas. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Zhang, Yingao, Savannah Barkdull, Panayiotis D. Kontoyiannis, Alejandra Flores Legarreta, David M. Gershenson, Preetha Ramalingam, Michael M. Frumovitz, and Anil K. Sood. TP53 and KRAS Co-mutations Are Associated with Worse Outcomes in Mucinous Ovarian Carcinomas. Frontiers Media S.A.

MLA (9th ed.) Citation

Zhang, Yingao, et al. TP53 and KRAS Co-mutations Are Associated with Worse Outcomes in Mucinous Ovarian Carcinomas. Frontiers Media S.A.